ebook Munafa Stock Market Course + Intraday & FNO calls  

       

VENUSREM announcements Venus Remedies Limited announcements and dividends declared NSE

Venus Remedies Limited Complete list of announcements declared & dividend announcements by Venus Remedies Limited VENUSREM

Venus Remedies Limited VENUSREM listed on NSE and deals in Pharmaceuticals

Announcements and dividends declared by Venus Remedies Limited VENUSREM

Company Announcement
Venus Remedies Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 24, 2023. Further, the company has informed the Exchange regarding voting results.
Announcement as on 28 August 2023

Venus Remedies gets marketing approval for anticoagulant drug in Saudi Arabia
Venus Remedies on Monday said it has received approval to market a drug, which prevents blood clots, in Saudi Arabia. The company has received the marketing approval for Enoxaparin in pre-filled syringes, the drug firm said in a statement on Monday.
Announcement as on 28 August 2023

Venus Remedies gains 5% on Saudi Arabia’s marketing approval for anti-coagulant drug
The company has said it has so far secured marketing authorisations from Saudi Arabia for six antibiotics meant for intensive care units and three oncology products
Announcement as on 28 August 2023

Company Announcement
Venus Remedies Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 24, 2023
Announcement as on 25 August 2023

Venus Remedies launches flagship R&D drug Elores in Oman
Venus Remedies has launched its R&D drug Elores, which is effective against multiple drug-resistant Gram-negative bacteria and has been patented in 46 countries including Japan and the US, in Oman's .5m antimicrobial market. Elores is aiming to capture 0
Announcement as on 18 August 2023

Announcements by Venus Remedies Limited first page | Next page | Prev page |

VENUSREM Venus Remedies Limited current price & indicator signals

Moving Averages for Venus Remedies Limited

  • 5Day Average: 1690.44
  • 12Day Average: 1531.49
  • 20Day Average: 1335.23
  • 50Day Average: 1112.85
  • 100Day Average: 867.34
  • 150Day Average: 708.53
  • 200Day Average: 608.69

VENUSREM Indicators & signals

Indicator MACD (12,26,9)

1541.12, 1344.64, 155.23
Indicator MACD is in positive zone

Indicator ADX (14)

75.1, 51.49, 7.32
Indicator ADX is indicating that momentum is still strong.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 65
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of VENUSREM Venus Remedies Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
12 Fri Jun 2026 1797.50 1706.80 to 1800.80 4.8% 1.19 times
11 Thu Jun 2026 1715.10 1625.70 to 1715.10 5% 0.85 times
10 Wed Jun 2026 1633.50 1571.00 to 1691.20 1.42% 1.34 times
09 Tue Jun 2026 1610.70 1610.70 to 1736.90 -5% 2.22 times
08 Mon Jun 2026 1695.40 1566.80 to 1715.10 3.79% 1.57 times
05 Fri Jun 2026 1633.50 1559.70 to 1633.50 4.99% 0.86 times
04 Thu Jun 2026 1555.80 1518.10 to 1555.80 4.99% 1.37 times
03 Wed Jun 2026 1481.80 1481.80 to 1481.80 5% 0.24 times
02 Tue Jun 2026 1411.30 1355.10 to 1411.30 5% 1.18 times
01 Mon Jun 2026 1344.10 1344.10 to 1344.10 5% 0.17 times
29 Fri May 2026 1280.05 1280.05 to 1280.05 5% 0.2 times
27 Wed May 2026 1219.10 1219.10 to 1219.10 5% 0.22 times

Videos related to: VENUSREM announcements Venus Remedies Limited announcements and dividends declared NSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

VENUSREM announcements Venus Remedies Limited announcements and dividends declared NSE

 

Back to top